NASDAQ:RDNT RadNet (RDNT) Stock Price, News & Analysis → Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (From InvestorPlace) (Ad) Free RDNT Stock Alerts $57.45 -0.13 (-0.23%) (As of 05/17/2024 ET) Add Compare Share Share Today's Range$57.11▼$58.5950-Day Range$43.87▼$58.2452-Week Range$25.11▼$58.59Volume303,107 shsAverage Volume515,678 shsMarket Capitalization$4.24 billionP/E Ratio191.50Dividend YieldN/APrice Target$57.25 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get RadNet alerts: Email Address RadNet MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.75 Rating ScoreUpside/Downside0.3% Downside$57.25 Price TargetShort InterestHealthy4.36% of Shares Sold ShortDividend StrengthN/ASustainability-0.52Upright™ Environmental ScoreNews Sentiment0.42Based on 12 Articles This WeekInsider TradingN/AProj. Earnings Growth8.47%From $0.59 to $0.64 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.04 out of 5 starsMedical Sector364th out of 914 stocksMedical Laboratories Industry9th out of 19 stocks 1.4 Analyst's Opinion Consensus RatingRadNet has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 3 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageRadNet has only been the subject of 4 research reports in the past 90 days.Read more about RadNet's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted4.36% of the outstanding shares of RadNet have been sold short.Short Interest Ratio / Days to CoverRadNet has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in RadNet has recently decreased by 0.62%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldRadNet does not currently pay a dividend.Dividend GrowthRadNet does not have a long track record of dividend growth. Previous Next 4.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreRadNet has received a 72.34% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Mammography services ", "Nuclear medicine imaging services", and "MRI services" products. See details.Environmental SustainabilityThe Environmental Impact score for RadNet is -0.52. Previous Next 1.9 News and Social Media Coverage News SentimentRadNet has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 12 news articles for RadNet this week, compared to 3 articles on an average week.Search InterestOnly 2 people have searched for RDNT on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, RadNet insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.43% of the stock of RadNet is held by insiders.Percentage Held by Institutions77.90% of the stock of RadNet is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about RadNet's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for RadNet are expected to grow by 8.47% in the coming year, from $0.59 to $0.64 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of RadNet is 191.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 122.32.Price to Earnings Ratio vs. SectorThe P/E ratio of RadNet is 191.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 100.50.Price to Book Value per Share RatioRadNet has a P/B Ratio of 3.94. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about RadNet's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 Media[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Are you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealthy beyond your wildest dreams. You see, while Bitcoin and Ethereum steal all the headlines… It’s often the cryptos flying under the radar that turn small stakes into life-changing windfalls. Claim your free seat by clicking here now. About RadNet Stock (NASDAQ:RDNT)RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.Read More RDNT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RDNT Stock News HeadlinesMay 19 at 3:32 AM | americanbankingnews.comTruist Financial Reaffirms "Buy" Rating for RadNet (NASDAQ:RDNT)May 15, 2024 | americanbankingnews.comRadNet (NASDAQ:RDNT) Cut to "Sell" at StockNews.comMay 14, 2024 | americanbankingnews.comRaymond James Increases RadNet (NASDAQ:RDNT) Price Target to $60.00May 14, 2024 | americanbankingnews.comRadNet (NASDAQ:RDNT) Sets New 12-Month High Following Analyst UpgradeMay 13, 2024 | globenewswire.comRadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024May 11, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) First-Quarter Results: Here's What Analysts Are Forecasting For This YearMay 10, 2024 | insidermonkey.comRadNet, Inc. (NASDAQ:RDNT) Q1 2024 Earnings Call TranscriptMay 10, 2024 | markets.businessinsider.comPeeling Back The Layers: Exploring RadNet Through Analyst InsightsMay 10, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies AheadMay 10, 2024 | finance.yahoo.comRadNet First Quarter 2024 Earnings: Beats ExpectationsMay 10, 2024 | finance.yahoo.comRadNet, Inc. (NASDAQ:RDNT) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?May 9, 2024 | msn.comRadNet GAAP EPS of -$0.04 beats by $0.02, revenue of $431.7M beats by $9.98MMay 9, 2024 | americanbankingnews.comRadNet (NASDAQ:RDNT) Rating Increased to Hold at StockNews.comMay 8, 2024 | washingtonpost.comRadNet: Q1 Earnings SnapshotMay 8, 2024 | msn.comRDNT Stock Earnings: RadNet Beats Revenue for Q1 2024May 8, 2024 | msn.comRadNet Q1 2024 Earnings PreviewMay 8, 2024 | globenewswire.comRadNet Reports First Quarter Financial Results with Record First Quarter Revenue, Adjusted EBITDA(1) and Adjusted Earnings(3) and Revises Upwards 2024 Financial Guidance RangesMay 7, 2024 | finance.yahoo.comRadNet’s Lenox Hill Radiology to Host Mother’s Day Mammogram Screening Parties in New York CityApril 29, 2024 | businesswire.comLoop Media Selected by RadNet to Provide Ad Sales Services, Branded Channels, and Customized Signage Across RadNetTVApril 25, 2024 | finance.yahoo.comThose who invested in RadNet (NASDAQ:RDNT) five years ago are up 299%April 22, 2024 | globenewswire.comRadNet, Inc. Announces Date of its First Quarter 2024 Financial Results Conference CallApril 18, 2024 | globenewswire.comRadNet Announces Closing of its Previously Announced Term Loan and Revolving Credit Facility Refinancing TransactionApril 18, 2024 | finance.yahoo.comRadNet’s Delaware Imaging Network Announces Ribbon-Cutting Ceremony for Mammography Service at Milford WalmartApril 18, 2024 | globenewswire.comRadNet's Delaware Imaging Network Announces Ribbon-Cutting Ceremony for Mammography Service at Milford WalmartApril 17, 2024 | finance.yahoo.comRadNet, Inc. (RDNT)See More Headlines Receive RDNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today5/18/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical laboratories Sub-IndustryN/A Current SymbolNASDAQ:RDNT CUSIPN/A CIK790526 Webwww.radnet.com Phone(310) 445-2800Fax310-445-2980Employees10,288Year Founded1980Price Target and Rating Average Stock Price Target$57.25 High Stock Price Target$63.00 Low Stock Price Target$48.00 Potential Upside/Downside-0.3%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)$0.30 Trailing P/E Ratio191.50 Forward P/E Ratio97.37 P/E GrowthN/ANet Income$3.04 million Net Margins1.28% Pretax Margin3.35% Return on Equity5.05% Return on Assets1.57% Debt Debt-to-Equity Ratio0.76 Current Ratio1.86 Quick Ratio1.32 Sales & Book Value Annual Sales$1.62 billion Price / Sales2.63 Cash Flow$3.32 per share Price / Cash Flow17.28 Book Value$14.58 per share Price / Book3.94Miscellaneous Outstanding Shares73,880,000Free Float70,607,000Market Cap$4.24 billion OptionableOptionable Beta1.69 Social Links Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesDr. Howard G. Berger M.D. (Age 78)Chairman, President & CEO Comp: $5.56MMr. Mark D. Stolper (Age 53)Executive VP & CFO Comp: $1.13MMr. Mital Patel (Age 38)Executive VP of Financial Planning & Analysis and Chief Administrative Officer Comp: $1.15MMr. Norman R. Hames (Age 68)President & COO of Western Operations Comp: $1.28MMr. Stephen M. Forthuber (Age 63)President & COO of Eastern Operations Comp: $1.3MMs. Christine Nayoma Gordon (Age 60)Senior VP of Operations - Northern California & Director Comp: $384.38kMr. Ranjan Jayanathan (Age 68)Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division Dr. A. Gregory Sorensen M.D. (Age 62)Executive VP, Chief Science Officer & Director Ms. Laura Foster BSRTMPH, J.D., Senior Vice President of Compliance & Regulatory AffairsMr. David Jeffrey Katz (Age 59)Executive VP, Chief Legal Officer & Corporate Secretary More ExecutivesKey CompetitorsGuardant HealthNASDAQ:GHFortreaNASDAQ:FTREVeracyteNASDAQ:VCYTCareDxNASDAQ:CDNAFulgent GeneticsNASDAQ:FLGTView All CompetitorsInsiders & InstitutionsCastleark Management LLCBought 149,723 shares on 5/17/2024Ownership: 0.203%Comerica BankSold 2,485 shares on 5/17/2024Ownership: 0.034%Silvercrest Asset Management Group LLCSold 7,942 shares on 5/16/2024Ownership: 0.531%Robotti RobertBought 1,070 shares on 5/16/2024Ownership: 0.394%California State Teachers Retirement SystemSold 6,656 shares on 5/16/2024Ownership: 0.078%View All Insider TransactionsView All Institutional Transactions RDNT Stock Analysis - Frequently Asked Questions Should I buy or sell RadNet stock right now? 4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" RDNT shares. View RDNT analyst ratings or view top-rated stocks. What is RadNet's stock price target for 2024? 4 Wall Street analysts have issued 12-month price objectives for RadNet's stock. Their RDNT share price targets range from $48.00 to $63.00. On average, they predict the company's share price to reach $57.25 in the next year. This suggests that the stock has a possible downside of 0.3%. View analysts price targets for RDNT or view top-rated stocks among Wall Street analysts. How have RDNT shares performed in 2024? RadNet's stock was trading at $34.77 at the start of the year. Since then, RDNT shares have increased by 65.2% and is now trading at $57.45. View the best growth stocks for 2024 here. When is RadNet's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024. View our RDNT earnings forecast. How were RadNet's earnings last quarter? RadNet, Inc. (NASDAQ:RDNT) announced its quarterly earnings data on Wednesday, May, 8th. The medical research company reported $0.07 earnings per share for the quarter, beating analysts' consensus estimates of ($0.09) by $0.16. The medical research company had revenue of $431.70 million for the quarter, compared to analyst estimates of $421.72 million. RadNet had a net margin of 1.28% and a trailing twelve-month return on equity of 5.05%. The business's revenue was up 10.5% on a year-over-year basis. During the same period last year, the company earned ($0.08) earnings per share. What ETFs hold RadNet's stock? ETFs with the largest weight of RadNet (NASDAQ:RDNT) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Services ETF (XHS), Invesco Dorsey Wright Healthcare Momentum ETF (PTH), Invesco S&P SmallCap Momentum ETF (XSMO), First Trust Small Cap Growth AlphaDEX Fund (FYC), SPDR S&P 600 Small Cap Growth ETF (SLYG), iShares S&P Small-Cap 600 Growth ETF (IJT) and iShares U.S. Healthcare Providers ETF (IHF). What guidance has RadNet issued on next quarter's earnings? RadNet updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. What is Howard G. Berger's approval rating as RadNet's CEO? 174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of RadNet own? Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T). Who are RadNet's major shareholders? RadNet's stock is owned by many different institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.23%), Principal Financial Group Inc. (2.11%), Hood River Capital Management LLC (1.45%), Global Alpha Capital Management Ltd. (1.38%), Edmond DE Rothschild Holding S.A. (1.19%) and Clearbridge Investments LLC (0.74%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson. View institutional ownership trends. How do I buy shares of RadNet? Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:RDNT) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsShocking $16T Elon Musk Crypto LeakCrypto 101 MediaBuy this small stock before coming AI Tidal WaveChaikin AnalyticsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHow Biden has already won 2024Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.